ASCO 2019 – The results of clinical practices changing phase III studies

At ASCO, a lot of attention is given to the results of the large, clinical practices changing phase III studies, but the future is also here. Early phase I and II trials, that test new molecules are also a highlight of the congress. Many of these studies are presented in smaller sessions. In the video below Kantar’s Otavio Clark comments about two of these studies, that have the potential to improve the care of patients.